DNMT1 and osteosarcoma: In fact, studies focused on DNA methylation pattern for drug repurposing in osteosarcoma (Chaiyawat et al., 2020) identified a significant increase in DNMT1-dependent chemosensitivity toward Cisplatin therapies when treated with Decitabine (DNMT inhibitor).